Login
Navigate Fool.com
Will MYL beat
the market?

Mylan Inc. (NASDAQ: MYL)

Community Rating: 4 Stars: Favorite

51.74 -0.16 (-0.31%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $51.29
Previous Close $51.90
Daily Range $51.10 - $51.88
52-Week Range $32.00 - $57.52
Market Cap $19.3B
P/E Ratio 32.04
Dividend (Yield) $0.00 (0.0%)
Volume 3,937,926
Average Daily Volume 4,109,088
Current FY EPS $3.39

How do you think MYL
will perform against the market?

Top MYL Bull/Bear Pitches

 

RXDOC73 (< 20)
Submitted October 28, 2008

The population is just getting older and more people are going to need more drugs. There is a great deal of consolidation in the field and only the strong companies like this one will survive the fal … More

1 Replies Reply Report this Post
 

DouglasRich (0)
Submitted January 29, 2008

Mylan is known for making good quality, reliable generic pharmaceutical products, but I think their primary drawback is they haven't found a way to outcompete the generic market. In the pharmacy, che … More

1 Replies Reply Report this Post

News & Commentary

Pfizer's Incoming Patent Cliff

Pfizer's loss of Lipitor's patent in 2012 slammed this top pharma stock. Will losses of Lyrica and other top drugs in coming years offer a repeat performance?

Is Teva Pharmaceuticals Stock Really Your Best Generic Drug Investment Option?

UBS likes Teva Pharmaceuticals among other generic drug companies, but should you?

How to stop corporations from fleeing the U.S. tax laws

Abbott Raises Full Year Earnings Guidance On Strong Q2 Results

Drugmaker in $54.7 billion merger aimed at cutting U.S. taxes

Drugmakers announce tax-cutting merger

Abbott Labs Stock Earnings: Why Steady Isn't Enough

Abbott did well on expenses, but driving better revenue growth needs to be the priority soon

What You Need to Know Ahead of Abbott Labs Earnings

Abbott Labs (ABT) is reporting earnings on July 16.

Nasdaq 100 Movers: MNST, MYL

Mylan and Abbott Just Got More Interesting

Here's what you need to know about Abbott selling part of its drug business to Mylan in a deal worth $5.3 billion.

Lew: Stop firms moving abroad to dodge tax

Lew urges action to combat corporate tax evasion

See More MYL News...

Sector

Healthcare

Industry

Drugs

Mylan Inc. (MYL) Description

The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients. Website: http://www.mylan.com/

More details for Mylan Inc Jobs
Mylan Inc reviews from employees

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks